Rifampin isoniazid pyrazinamide labels and packages: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
Gerald Chi (talk | contribs) mNo edit summary |
||
| (3 intermediate revisions by 2 users not shown) | |||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{ | {{Rifampin isoniazid pyrazinamide}} | ||
{{CMG}}; {{AE}} {{chetan}} | {{CMG}}; {{AE}} {{chetan}} | ||
==Labels | ==Labels and Packages== | ||
PRINCIPAL DISPLAY PANEL - 60 Tablet Bottle<ref name="dailymed.nlm.nih.gov">{{Cite web | last = | first = | title = RIFATER (RIFAMPIN, ISONIAZID AND PYRAZINAMIDE) TABLET, SUGAR COATED [SANOFI-AVENTIS U.S. LLC] | url = http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=429a2f62-9fe6-4299-b314-92a9d22b1381 | publisher = | date = | accessdate }}</ref> | PRINCIPAL DISPLAY PANEL - 60 Tablet Bottle<ref name="dailymed.nlm.nih.gov">{{Cite web | last = | first = | title = RIFATER (RIFAMPIN, ISONIAZID AND PYRAZINAMIDE) TABLET, SUGAR COATED [SANOFI-AVENTIS U.S. LLC] | url = http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=429a2f62-9fe6-4299-b314-92a9d22b1381 | publisher = | date = | accessdate }}</ref> | ||
| Line 9: | Line 9: | ||
Rifater® | Rifater® | ||
rifampin, isoniazid | rifampin, isoniazid and pyrazinamide | ||
and pyrazinamide | |||
60 Tablets | 60 Tablets | ||
Sanofi Aventis | |||
{| | {| | ||
|- | |- | ||
| [[File:|800px|thumb]] | | [[File:RIFATER6.jpg|800px|thumb]] | ||
|- | |- | ||
|} | |} | ||
==References== | ==References== | ||
Latest revision as of 23:50, 3 January 2014
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Chetan Lokhande, M.B.B.S [2]
Labels and Packages
PRINCIPAL DISPLAY PANEL - 60 Tablet Bottle[1]
NDC 0088-0576-41
Rifater® rifampin, isoniazid and pyrazinamide
60 Tablets
Sanofi Aventis
 |
References
- ↑ "RIFATER (RIFAMPIN, ISONIAZID AND PYRAZINAMIDE) TABLET, SUGAR COATED [SANOFI-AVENTIS U.S. LLC]". Text " accessdate " ignored (help)
Adapted from the FDA Package Insert.